VIMOVO

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Dostupné z:

ASTRA ZENECA ISRAEL LTD

ATC kód:

G02CC02

Forma lieku:

TABLETS MODIFIED RELEASE

Spôsob podávania:

PER OS

Výrobca:

ASTRA ZENECA AB., SWEDEN

Terapeutické skupiny:

NAPROXEN

Terapeutické indikácie:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Dátum Autorizácia:

2011-12-01